The AFLOAT trial showed that atrial arrhythmias were commonly noted post-PFO closure on systematic intracardiac monitoring, but flecainide did not reduce the incidence of these atrial arrhythmias. All ...
GUARD-AF was a randomized prospective trial to assess whether screening for atrial fibrillation (AF) using a 14-day continuous electrocardiographic (ECG) monitor in people ≥70 years seen in primary ...
Zhang Y, Yu S, Chen Z, et al. In Mendelian randomization analyses, genetic predisposition to GDM was associated with increased risk of coronary artery disease (odds ratio, 1.09 [95% confidence ...
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode three of four, Ms. Amy Brownell will interview Ms. Corrin McCloskey and Dr. Joseph Goeke on developing a ...
Rasmussen LD, Schmidt SE, Knuuti J, et al. There were 13,748 individuals included in this pooled study, and the primary endpoint was observed in 2.3% (n = 313) of patients. Very-low, low, and moderate ...
The following are key points to remember from a state-of-the-art review on multimodality imaging in the diagnostic work-up of patients with cardiac masses: ...
Patients can benefit from better healthcare access and outcomes by services that are enabled by artificial intelligence (AI). The current state of technology is evolving to now allow diagnosis of ...
New to this year's Summit, the Chest Pain Solution Room offered participants of the Chest Pain – MI Registry and Chest Pain Center Accreditation the opportunity to interact with each other in a ...
In this special edition of Eagle’s Eye View, Dr. Eagle looks four of the most important trials presented at the recent TCT Conference: 1) EARLY TAVR evaluating TAVR compared to clinical surveillance; ...
Galli M, Gragnano F, Berteotti M, et al., on behalf of the Working Group of Thrombosis of the Italian Society of Cardiology. Citation: Antithrombotic Therapy in High Bleeding Risk Part II: Non-Cardiac ...
Patients younger than 65 years who received balloon-expandable valve TAVR for severe aortic stenosis during the low-surgical risk era were more likely to have comorbidities and exhibited higher rates ...
In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients. He then explores the comparative effectiveness and safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback